Old Web
English
Sign In
Acemap
>
Paper
>
A Phase 1 Safety Study of an Orally Available Tyrosine Kinase Inhibitor X-82 in Previously Treated Wet AMD Patients
A Phase 1 Safety Study of an Orally Available Tyrosine Kinase Inhibitor X-82 in Previously Treated Wet AMD Patients
2015
Philip J. Rosenfeld
Jason S. Slakter
David S. Boyer
David M. Brown
Nauman A Chaudhry
Michael J. Elman
Sunil S. Patel
Denis O’Shaughnessy
Keywords:
Tyrosine-kinase inhibitor
Biology
Diabetes mellitus
Pharmacology
Anatomy
previously treated
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]